loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of suppliers providing reference standards related to Darifenacin

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Creative Peptides (1)

02 USP (3)

filter

01 133099-04-4 (1)

02 133099-07-7 (1)

03 Blank (2)

filter

01 Darifenacin hydrobromide is used to treat people who have urinary problems such as urinary incontinence, urinary urgency or urinary frequency which are caused by an overactive bladder. It works by preventing spasms of the bladder?muscle. This can help to reduce the episodes of urinary incontinence, the frequency of urination or reduce the feeling of urgency that bladder spasms can cause. More information please visit the website: http://www.creative-peptides.com/product/darifenacin-hydrobromide- (1)

02 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No (3)

filter

01 U.S.A (4)

Darifenacin Hydrobromide

URL Supplier Web Content
133099-04-4
Darifenacin hydrobromide ...
10-101-114
Product List
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

USP

Contact Supplier

    Darifenacin Chiral Peak ID Mixture (25 mg) (See USP Cer...

    URL Supplier Web Content
    25
    mg
    Material Origin- Chemical...
    $581.25
    Catalog #1164211 / F04970
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    USP

    Contact Supplier

      Darifenacin Peak ID Mixture (25 mg) (A mixture consisti...

      URL Supplier Web Content
      25
      mg
      Material Origin- Chemical...
      $547.50
      Catalog #1164222 / F04980
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      USP

      Contact Supplier

        Darifenacin Hydrobromide (150 mg)

        URL Supplier Web Content
        133099-07-7
        150
        mg
        Material Origin- Chemical...
        $585.00
        Catalog #1164200 / F04960
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Post Enquiry
        POST ENQUIRY